SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Solara Active Pharma Sciences gets nod to sell 100% stake in SeQuent Penems

26 Mar 2024 Evaluate

Solara Active Pharma Sciences has received approval from board of directors to sell 100% shareholding in SeQuent Penems. The board of directors of the company at its meeting held on March 25, 2024 approved the same.  

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Solara Active Pharma Share Price

576.85 5.00 (0.87%)
03-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1904.65
Dr. Reddys Labs. 1374.55
Cipla 1458.45
Zydus Lifesciences 1141.00
Lupin 2476.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: